YOOYOUNG

Products/R&D

Yooyoung providing search service for
our products as well as our R&D.

About our factory

Our factory located at Jincheon, Korea, which was designed with a cutting-edge facility at GMP level by consulting renowned domestic and international firms to manufacture and distribute the highest quality pharmaceutical product possible with our high-standard Quality Management System, is manufacturing and distributing finished drug products (OSD, prefilled syringes, ampoules for injections) and medical equipment. Especially, we are specializing in products based on hyaluronic acid, and have developed arthritis medication "Atri", "Atriplus injection", single-use osteoarthritis treatment Resyno-one injection, and fillers to decrease wrinkles. Also, our export revenue for OSD, injections, and fillers to many countries such as Japan, and many others in Asia, Europe, and South America have exceeded 10 million dollars each year, and our company was awarded with 10 million dollars export tower in 2021.

Also, our Jincheon factory received good reviews from visiting agencies and is recognized in many places as we were awarded with excellence award in quality management and the grand prize in quality management.

GMP system extension summary

Size	Factory	Extension & Remodeling	Storage extension
Land	23000㎡ [approximately 7000 py]		-
Building	15000m²	1,862.17m²[563 py]	759.46㎡ [230 py]
Ground breaking	2005.09	2022.05	2023.12
Facilities	Pharmaceuticals manufacturing building, automated storage, quality control building, facility maintenance building, offices	Additional extension - prefilled syringe injection manufacturing plant (1,862.17m²)	Storage extension

Ampoule manufacturing line

OSD tablet manufacturing line

Automated tablet&capsule sorter

water processing system

Packaging room line

export manufacturing line

automated storage

Blister packaging equipment

ampoule filling machine

Extension of prefilled syringe injection manufacturing line

◼ Extension of additional manufacturing plant to manufacture, sterilize, and terminal-sterilize 10 million syringes per year

◼ Aiming to produce high-quality pharmaceutical products through an automated, mass production system using cutting-edge manufacturing equipment

∙Total manufacturing capacity : 15 milion syringes

∙Current employees : 140

◼ Introducing main manufacturing facilities

Our manufacturing plant has a capacity of 800 million OSD tablets, 25 million ampoules for injections, and 5 million prefilled syringes per year. By completing the extension on prefilled syringe manufacturing line in 2021, we aim to manufacture 15 million syringes per year, improving our high-quality manufacturing capacity even more.

◼ Commissioned projects

Commissioned formulation	solid formulation uncoated tablet, coated tablet, hard capsules
Commissioned formulation	injection prefilled syringe (1,3,5 mL)
Employee in charge	Mr. Sangjo Lee, CMO (Team Leader)
Phone	02-6202-7117
Switchboard	043-539-8800

◼ ︎Current International accreditations/certifications

∙2009 PMDA(Japan) GMP certification - Pharmaceutical (OSD tablets)

∙2012 PMDA(Japan) GMP certification - Pharmaceutical (OSD tablets, Injections)

∙2012 CE(Europe) / ISO 13485 certification - Medical device (Hyaluronic acid injection)

∙2018 PMDA(Japan) GMP renewal - Pharmaceutical (OSD tablets)

∙2021 CE(Europe) / ISO 13485 renewal - Medical device (Hyaluronic acid injection)

∙2021 TFDA(Taiwan) QSD certification - Medical device

∙2023 CE(Europe) / ISO 13485 renewal - Medical device (Hyaluronic acid injection)

∙2024 CE(Europe) / ISO 13485 post-market surveillance & change audit - Medical device (Hyaluronic acid injection)/div>